Skip to main content
. 2018 Mar 12;172(5):423–430. doi: 10.1001/jamapediatrics.2017.5641

Table 2. Prior Mental Health Conditions and Treatments and Long-term Opioid Therapy Among 1 000 453 Adolescents.

Prior Mental Health Factor Long-term Opioids per 1000 Recipients Within 3 ya Hazard Ratio (95% CI)
No Predictor With Predictor Unadjustedb Adjustedc
Anxiety
Anxiety disorder 2.8 8.0 2.72 (2.42-3.06) 2.69 (2.39-3.03)
Benzodiazepine 2.8 12.2 4.07 (3.56-4.66) 3.88 (3.39-4.45)
Mood
Bipolar or other mood disorder 2.8 10.1 3.33 (2.86-3.87) 3.28 (2.81-3.82)
Depressive disorder 2.6 9.0 3.15 (2.86-3.46) 3.01 (2.73-3.31)
Suicide attempt or self-injury 3.0 6.0 3.05 (1.73-5.38) 3.16 (1.79-5.58)
Mood stabilizer 2.9 10.3 3.12 (2.46-3.96) 3.01 (2.37-3.82)
SNRI 2.9 14.8 4.58 (3.59-5.85) 3.93 (3.08-5.02)
SSRI 2.6 9.1 3.11 (2.82-3.43) 2.95 (2.67-3.25)
Neurodevelopment
ADHD 2.9 4.5 1.64 (1.46-1.84) 1.73 (1.54-1.95)
ADHD medication 2.8 4.7 1.67 (1.50-1.85) 1.74 (1.56-1.94)
Psychosis
Schizophrenia spectrum disorder 3.0 6.7 3.02 (2.11-4.32) 2.96 (2.07-4.24)
Antipsychotic 2.8 11.3 3.59 (3.08-4.18) 3.58 (3.08-4.17)
Sleep
Sleep disorder 2.9 10.8 3.58 (3.01-4.24) 3.53 (2.97-4.19)
Nonbenzodiazepine hypnotic 2.9 24.2 6.93 (5.65-8.50) 6.15 (5.01-7.55)
Substance use
Nonopioid SUD 2.8 12.7 4.33 (3.75-5.00) 4.02 (3.48-4.65)
OUD 3.0 27.5 9.74 (6.41-14.82) 8.90 (5.85-13.54)
OUD medication 3.0 22.4 9.83 (4.69-20.63) 8.50 (4.05-17.84)
Psychotherapy
For any diagnosis 2.6 5.9 2.14 (1.95-2.34) 2.10 (1.92-2.30)

Abbreviations: ADHD, attention-deficit/hyperactivity disorder; OUD, opioid use disorder; SNRI, serotonin-norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; SUD, substance use disorder.

a

Three-year cumulative incidence per 1000 opioid recipients.

b

Unadjusted Cox proportional hazards regression analysis.

c

Adjusted for sex, index age, and index year.